MedPath

EMD SERONO, INC.

EMD SERONO, INC. logo
🇺🇸United States
Ownership
Subsidiary
Established
1981-01-01
Employees
1K
Market Cap
-
Website
http://www.emdserono.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

FDA:11

Drug Approvals

Gonal-f

Approval Date
Jun 20, 2025
FDA

BAVENCIO

Approval Date
Mar 19, 2024
FDA

Mavenclad

Approval Date
Mar 13, 2024
FDA

TEPMETKO

Approval Date
Feb 23, 2024
FDA

Ovidrel

Approval Date
Dec 26, 2023
FDA

Cetrotide

Approval Date
Dec 22, 2023
FDA

GONAL-F RFF

Approval Date
Nov 20, 2023
FDA

Rebif

Approval Date
Aug 4, 2023
FDA

Saizen

Approval Date
Jun 19, 2023
FDA

Serostim

Approval Date
Feb 2, 2022
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath